Gene silencing innovation creating infrastructure — antisense oligonucleotide therapeutics targeting disease-causing messenger RNA enabling novel treatment approaches for previously untreatable genetic diseases, establishing antisense therapy as essential RNA-targeted therapeutic infrastructure, with the Antisense Oligonucleotide Therapeutics Pipeline Insight Market experiencing rapid...